Tommy was given a tour of the Bills facility in his hometown and met with head coach Sean McDermott as part of his ...

The co-owner, Chad Day, has been a part of the fundraising efforts for the six-year-old with Duchenne muscular dystrophy.

ABEL Motorsports driver Callum Hedge (photo) is trying to raise awareness and funds to combat muscular dystrophy in his ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Dyne Therapeutics (DYN) announced that the European Commission has granted orphan drug designation for DYNE-251 for the treatment of Duchenne ...

Dyne anticipates filing a Biologics License Application (BLA) submission for US accelerated approval in early 2026.

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

The Jaffa Shriners’ DuBois Area Shrine Club continues to support a wheelchair program that provides essential equipment to ...

Dyne Therapeutics, Inc.’s DYN share price has surged by 9.28%, which has investors questioning if this is right time to sell.

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as ...

For most parents, newborn screening tests are a barely perceptible safety net. But for the small minority whose babies get ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.